Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin irritation: in vivo
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
other: Body responsible for the test
Title:
Unnamed
Year:
1995

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: Basierend auf der Vorschrift der Kommission Fur Product-sicherheit fur den Verbraucher der Vereinigten Staaten von Amerika (Federal Regulation(CFR),par.16,Absaiz 15.41)
GLP compliance:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
4-(1-oxo-2-propenyl)-morpholine
EC Number:
418-140-1
EC Name:
4-(1-oxo-2-propenyl)-morpholine
Cas Number:
5117-12-4
Molecular formula:
C7H11NO2
IUPAC Name:
4-(1-oxo-2-propenyl)-morpholine

Test animals

Species:
other: rbt.Weibe Neuseelander

Test system

Type of coverage:
occlusive
Vehicle:
other: none
Duration of treatment / exposure:
24h
Number of animals:
6

Results and discussion

In vivo

Resultsopen allclose all
Irritation parameter:
erythema score
Basis:
mean
Score:
0.5
Max. score:
1
Remarks on result:
other: Max duration: 3d; Max.Value at end of observation period:0
Irritation parameter:
erythema score
Basis:
mean
Score:
0
Max. score:
0
Remarks on result:
other: Max. duration:0d; Max.value at end of observation period:0
Irritant / corrosive response data:
Reversibility of any observaion effect: Changes fully reversible within 3 days.
Other effects:
Results in the table refer to the intact skin.
The abraded sdkin was observed at the same time. The average for erythemae was 0.8 and for edemae0.
The max.Value for arythema was 1 and for edema 0. The max.
Duration was < 3 days.
The maximal values at the end of the study: 0.

Applicant's summary and conclusion

Interpretation of results:
other: not classified